Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Encephalitis in the Immunocompromised: Clinical Presentation, Diagnostic Findings, Treatment, and Comparison of Infectious and Autoimmune Etiologies

Author:Kolchinski, Anna   Li, Margaret   Habis, Ralph   Probasco, John   Hasbun, Rodrigo   Venkatesan, Arun   

Session Name:S4: Autoimmune Neurology: Autoimmune Encephalitis and Neuronal Autoantibodies  

Topic:Autoimmune Neurology  

Program Number:S4.009  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD  Johns Hopkins University, Baltimore, MD  The Johns Hopkins Hospital, Baltimore, MD  University of Texas Houston, Houston, TX  

Frequency and Cost of Anti-neural Antibody Testing for Autoimmune Encephalitis in a Large Canadian Health Region

Author:Roberts, Jodie   Greenfield, Jamie   Yaraskavitch, Megan   Hahn, Christopher   

Session Name:S4: Autoimmune Neurology: Autoimmune Encephalitis and Neuronal Autoantibodies  

Topic:Autoimmune Neurology  

Program Number:S4.010  

Author Institution:University of Calgary, Calgary, AB, Canada  

Pridopidine for the Treatment of ALS—Results from the Phase 2 Healey ALS Platform Trial

Author:Shefner, Jeremy   Oskarsson, Bjorn   Cohen, Yael   Chen, Kelly   Leitner, Melanie   Berry, James   Macklin, Eric   Chibnik, Lori   Pothier, Lindsay   Geva, Michal   Goldberg, Paul   Hayden, Michael   Paganoni, Sabrina   Cudkowicz, Merit   

Session Name:S5: ALS and CMT: New Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S5.003  

Author Institution:Barrow Neurological Institute, Phoenix, AZ  Mayo Clinic, Jacksonville, FL  Prilenia Therapeutics, Kibbutz Yakum, Israel  Accelerating NeuroVentures, LLC, Needham, MA  Massachusetts General Hospital, Boston, MA  Prilenia Therapeutics, Herzlyia, Israel  

Results from a Phase 2 Clinical Trial of Repeated Intrathecal Autologous Adipose-derived MSCs in ALS

Author:Staff, Nathan   Oskarsson, Bjorn   Muzyka, Iryna   Madigan, Nicolas   Mester, Carly   Figdore, Daniel   Turner, Michelle   Thuro, Lisa   Osgood, Thomas   Madde, Pranathi   Deeds, Michael   Wiltshire, Timothy   Algeciras-Schimnich, Alicia   Mandrekar, Jayawant   Dietz, Allan   Windebank, Anthony   

Session Name:S5: ALS and CMT: New Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S5.004  

Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic Florida, Jacksonville, FL  Mayo Clinic Arizona, Scottsdale, AZ  

Value of FVC and its Rate of Decline for Predicting Survival in ALS

Author:Seyam, Muhannad   Hubbell, Richard   Howard, Diantha   Skelly, Joan   Waheed, Waqar   Tandan, Rup   

Session Name:S5: ALS and CMT: New Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S5.005  

Author Institution:University of Vermont Medical Center, Burlington, VT  University of Vermont, Burlington, VT